来源 | The Information 在过去一年里，投资人Brian Sugar觉得自己仿佛获得了一种"超能力"。无论是在家、健身房还是办公室，他发现自己总能突破极限，把自己推向前所未 有的新状态。 他将这种神奇的转变归功于一种名为司美格鲁肽的药物。 这股风潮如今正席卷硅谷精英圈：越来越多的人不再将GLP-1类药物仅仅视为减肥工具，而是看作提升生活方式和思维效率的"秘密武器"。Sugar直 言："这就像在给大脑编程。" GLP-1类药物正在迅速融入科技界的日常。 科技媒体《The Information》上周的一项读者调查显示，在近千名受访者中，竟有50.5%的人表示自己正在使用这类药物，远高于普通人群。 微剂量实验 一些用户开始采用所谓"微剂量"方式：并不按常规逐步加量，而是长期维持较低剂量。他们认为这样既能获得药效，又能减少恶心等副作用。 市场营销高管Craig Atkinson就是其中之一。他发现起始剂量已足够有效，因此没有再增加用量。他减掉了约15磅（6.8公斤），更重要的是，能够在工 作和社交场合更轻松地控制饮食。"小剂量足以抑制不必要的欲望。" Atkinson服用的替尔泊肽（tirzepat ...

Core Insights - The article discusses the rising trend of GLP-1 drugs, particularly semaglutide and tirzepatide, among Silicon Valley elites, who are using these medications not just for weight loss but also for enhancing cognitive function and overall lifestyle optimization [5][11][12]. Group 1: Usage and Perception - A survey indicated that 50.5% of respondents in the tech industry are using GLP-1 drugs, significantly higher than the general population [6]. - Users are adopting "micro-dosing" strategies to maintain lower doses of the medication, which they believe can provide benefits while minimizing side effects [8]. - Many tech professionals view GLP-1 drugs as tools for "biohacking," aiming to improve energy levels and cognitive performance during demanding work situations [11]. Group 2: Competitive Advantage - GLP-1 drugs, initially developed for diabetes treatment, are now being recognized for their potential benefits in weight management and cognitive enhancement [12]. - Users report significant lifestyle improvements, such as reduced cravings and better focus during meetings, which they attribute to the effects of GLP-1 medications [10][13]. - The trend is particularly strong among individuals seeking competitive advantages in their professional lives, with some users feeling empowered and more confident in their decision-making [11][13]. Group 3: Market Dynamics - Companies in the healthcare sector are increasingly focusing on GLP-1 drugs, with remote healthcare services expanding their offerings to include these medications [15]. - The rise of GLP-1 drugs has led to a shift in consumer habits, with companies like Hims and Noom integrating these medications into their business models [15][16]. - The article highlights the potential for significant market growth as more individuals seek out GLP-1 drugs for both weight management and overall health optimization [16].